If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Elena Verzoni is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 32 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Real-world data on cabozantinib in previously treated patients with metastatic renal cell carcinoma: Focus on sequences and prognostic factors

Santoni, M., Heng, D. Y., Bracarda, S., Procopio, G., Milella, M., Porta, C., Matrana, M. R., Cartenì, G., Crabb, S. J., De Giorgi, U., Basso, U., Masini, C., Calabrò, F., Vitale, M. G., Santini, D., Massari, F., Galli, L., Fornarini, G., Ricotta, R., Buti, S. & 29 others, Zucali, P., Caffo, O., Morelli, F., Carrozza, F., Martignetti, A., Gelibter, A., Iacovelli, R., Mosca, A., Atzori, F., Vau, N., Incorvaia, L., Ortega, C., Scarpelli, M., Lopez-Beltran, A., Cheng, L., Paolucci, V., Graham, J., Pierce, E., Scagliarini, S., Sepe, P., Verzoni, E., Merler, S., Rizzo, M., Sorgentoni, G., Conti, A., Piva, F., Cimadamore, A., Montironi, R. & Battelli, N., Jan 2020, In : Cancers. 12, 1, 84.

Research output: Contribution to journalArticle

Open Access
  • Cabozantinib in Renal Cell Carcinoma With Brain Metastases: Safety and Efficacy in a Real-World Population

    Peverelli, G., Raimondi, A., Ratta, R., Verzoni, E., Bregni, M., Cortesi, E., Cartenì, G., Fornarini, G., Facchini, G., Buti, S., Galli, L., Tucci, M., Prisciandaro, M. & Procopio, G., Aug 1 2019, In : Clinical Genitourinary Cancer. 17, 4, p. 291-298 8 p.

    Research output: Contribution to journalArticle

  • Collecting ducts carcinoma: An orphan disease. Literature overview and future perspectives

    Pagani, F., Colecchia, M., Sepe, P., Apollonio, G., Claps, M., Verzoni, E., de Braud, F. & Procopio, G., Sep 2019, In : Cancer Treatment Reviews. 79, 101891.

    Research output: Contribution to journalReview article

  • Open Access
  • Real-World Data on Cabozantinib in Previously Treated Patients with Metastatic Renal Cell Carcinoma: Focus on Sequences and Prognostic Factors

    Santoni, M., Heng, D. Y., Bracarda, S., Procopio, G., Milella, M., Porta, C., Matrana, M. R., Cartenì, G., Crabb, S. J., De Giorgi, U., Basso, U., Masini, C., Calabrò, F., Vitale, M. G., Santini, D., Massari, F., Galli, L., Fornarini, G., Ricotta, R., Buti, S. & 29 others, Zucali, P., Caffo, O., Morelli, F., Carrozza, F., Martignetti, A., Gelibter, A., Iacovelli, R., Mosca, A., Atzori, F., Vau, N., Incorvaia, L., Ortega, C., Scarpelli, M., Lopez-Beltran, A., Cheng, L., Paolucci, V., Graham, J., Pierce, E., Scagliarini, S., Sepe, P., Verzoni, E., Merler, S., Rizzo, M., Sorgentoni, G., Conti, A., Piva, F., Cimadamore, A., Montironi, R. & Battelli, N., Dec 30 2019, In : Cancers. 12, 1

    Research output: Contribution to journalArticle